Johnson & Johnson begun a Stage III trial for its vaccine candidate in September 2020, but paused it on October twelve due to an unexplained health issues and remains on maintain. The corporation announced it might restart the trial on Oct 26. Pauses are common in the course of medical http://minern024nrt0.mdkblog.com/profile